Author: Neha Jain; Uma Shankar; Prativa Majee; Amit Kumar
Title: Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopes Document date: 2020_4_1
ID: lmstdmyb_3
Snippet: With the continuous transmission of the virus across borders and increasing health burden on the global scale, SARS-CoV-2 demands an urgent immunization therapy. As depicted by Shan Lu, the Community Acquired Coronavirus Infection (CACI) caused by this virus can shatter the socio-economic condition worldwide and the development of vaccine against the SARS-CoV-2 should be encouraged to manage the present situation as well as it can serve as a prot.....
Document: With the continuous transmission of the virus across borders and increasing health burden on the global scale, SARS-CoV-2 demands an urgent immunization therapy. As depicted by Shan Lu, the Community Acquired Coronavirus Infection (CACI) caused by this virus can shatter the socio-economic condition worldwide and the development of vaccine against the SARS-CoV-2 should be encouraged to manage the present situation as well as it can serve as a prototype for other coronaviruses [30, 31] . Thereby, our analysis provides a platform for the development of a protective vaccine candidate that can be tested in-vitro and in-vivo and may lead to faster development of an efficient vaccine against the SARS-CoV-2 infection.
Search related documents:
Co phrase search for related documents- continuous transmission and SARS infection: 1, 2, 3, 4, 5
- efficient vaccine and fast development: 1, 2
- efficient vaccine and global scale: 1, 2, 3, 4
- efficient vaccine and health burden: 1
- efficient vaccine and present situation: 1
- efficient vaccine and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- efficient vaccine and SARS infection efficient vaccine: 1
- efficient vaccine and SARS vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- efficient vaccine and SARS vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9
- fast development and health burden: 1, 2, 3, 4, 5
- fast development and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- fast development and SARS vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- fast development and SARS vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- global scale and health burden: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- global scale and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- global scale and SARS vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- global scale and SARS vaccine development: 1
- health burden and SARS vaccine development: 1, 2, 3
- health burden and socio economic condition: 1
Co phrase search for related documents, hyperlinks ordered by date